These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 16453359)

  • 1. The ether lipid inositol-C2-PAF is a potent inhibitor of cell proliferation in HaCaT cells.
    Fischer A; Müller D; Zimmermann-Kordmann M; Kleuser B; Mickeleit M; Laabs S; Löwe W; Cantagrel F; Reutter W; Danker K
    Chembiochem; 2006 Mar; 7(3):441-9. PubMed ID: 16453359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of alkylphospholipids on the gene expression profile of HaCaT cells.
    Semini G; Klein A; Danker K
    Pharmacogenet Genomics; 2011 Jul; 21(7):375-87. PubMed ID: 21681147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inositol-C2-PAF down-regulates components of the antigen presentation machinery in a 2D-model of epidermal inflammation.
    Semini G; Hildmann A; Klein A; Lucka L; Schön M; Schön MP; Shmanai V; Danker K
    Biochem Pharmacol; 2014 Feb; 87(3):477-88. PubMed ID: 24291779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosidated phospholipids - a promising group of anti-tumour lipids.
    Semini G; Hildmann A; von Haefen C; Danker K
    Anticancer Agents Med Chem; 2014 May; 14(4):607-17. PubMed ID: 24628240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inositoylated platelet-activating factor (Ino-C2-PAF) modulates dynamic lymphocyte-endothelial cell interactions and alleviates psoriasis-like skin inflammation in two complementary mouse models.
    Forkel S; Schön M; Hildmann A; Claßen A; John SM; Danker K; Schön MP
    J Invest Dermatol; 2014 Oct; 134(10):2510-2520. PubMed ID: 24714204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosidated phospholipids: uncoupling of signalling pathways at the plasma membrane.
    Danker K; Reutter W; Semini G
    Br J Pharmacol; 2010 May; 160(1):36-47. PubMed ID: 20331609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The novel synthetic ether lipid inositol-C2-PAF inhibits phosphorylation of the tyrosine kinases Src and FAK independent of integrin activation in transformed skin cells.
    Semini G; Hildmann A; Reissig HU; Reutter W; Danker K
    Biochem Pharmacol; 2011 Apr; 81(8):985-95. PubMed ID: 21320472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inositol-C2-PAF acts as a biological response modifier and antagonizes cancer-relevant processes in mammary carcinoma cells.
    Pelz C; Häckel S; Semini G; Schrötter S; Bintig W; Stricker S; Mrawietz G; Klein A; Lucka L; Shmanai V; Eickholt B; Hildmann A; Danker K
    Cell Oncol (Dordr); 2018 Oct; 41(5):505-516. PubMed ID: 30047091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-dependent effects of glucose-containing analogs of platelet activating factor (PAF) on membrane integrity.
    Wiese A; Wieder T; Mickeleit M; Reinöhl S; Geilen CC; Seydel U; Reutter W
    Biol Chem; 2000 Feb; 381(2):135-44. PubMed ID: 10746745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucosamine-glycerophospholipids that activate cell-matrix adhesion and migration.
    Bartolmäs T; Heyn T; Mickeleit M; Fischer A; Reutter W; Danker K
    J Med Chem; 2005 Oct; 48(21):6750-5. PubMed ID: 16220990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAF-agonistic and -antagonistic behaviour of new synthetic ether phospholipids. I. Studies on blood platelets in vitro.
    Ostermann G; Hofmann B; Kertscher HP; Till U
    J Lipid Mediat; 1990; 2(1):21-31. PubMed ID: 1966804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific binding of antibodies to platelet-activating factor (PAF) as demonstrated by thin-layer chromatography/immunostaining.
    Karasawa K; Satoh N; Hongo T; Nakagawa Y; Setaka M; Nojima S
    Lipids; 1991 Dec; 26(12):1122-5. PubMed ID: 1819697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Penicillium sp. F33 metabolite and its synthetic derivatives inhibit acetyl-CoA:1-O-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and carrageenan-induced paw edema in mice.
    Yamazaki Y; Yasuda K; Matsuyama T; Ishihara T; Higa R; Sawairi T; Yamaguchi M; Egi M; Akai S; Miyase T; Ikari A; Miwa M; Sugatani J
    Biochem Pharmacol; 2013 Sep; 86(5):632-44. PubMed ID: 23817078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interaction of 1-O-alkyl-2-methoxy-sn-glycero-3-phosphocholine and platelet activating factor with blood and tumor cells].
    Muzia GI; Orlov SM; Berdyshev EV; Kulikov VI
    Biokhimiia; 1994 Jul; 59(7):1054-61. PubMed ID: 7948414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic glycosidated phospholipids induce apoptosis through activation of FADD, caspase-8 and the mitochondrial death pathway.
    von Haefen C; Wendt J; Semini G; Sifringer M; Belka C; Radetzki S; Reutter W; Daniel PT; Danker K
    Apoptosis; 2011 Jun; 16(6):636-51. PubMed ID: 21437721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autocrine stimulation of B lymphocytes by a platelet-activating factor receptor agonist, 1-palmitoyl-2-acetyl-sn-glycero-3-phosphocholine.
    Tordai A; Franklin RA; Johnson C; Mazer BD; Clay KL; Gelfand EW
    J Immunol; 1994 Jan; 152(2):566-73. PubMed ID: 8283038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-activating factor stimulates phosphatidic acid formation in cultured rat mesangial cells: roles of phospholipase D, diglyceride kinase, and de novo phospholipid synthesis.
    Kester M
    J Cell Physiol; 1993 Aug; 156(2):317-25. PubMed ID: 8393878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pertussis toxin and B-oligomer on platelet-activating factor-induced generation of inositol phosphates in porcine alveolar macrophages.
    Dodam JR; Adler KB; Olson NC
    Am J Vet Res; 1996 Apr; 57(4):574-9. PubMed ID: 8712527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human endothelial cells are target for platelet-activating factor. II. Platelet-activating factor induces platelet-activating factor synthesis in human umbilical vein endothelial cells.
    Heller R; Bussolino F; Ghigo D; Garbarino G; Pescarmona G; Till U; Bosia A
    J Immunol; 1992 Dec; 149(11):3682-8. PubMed ID: 1431139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acyl and plasmalogen analogs of platelet activating factor--new lipid cellular bioregulators].
    Kulikov VI; Muzia GI
    Biokhimiia; 1992 Jun; 57(6):803-16. PubMed ID: 1420585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.